Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 5,000 shares at $31.46 ($157K) on 2017-04-24, disclosed to the SEC on 2017-04-26.
Scheduled sale ($157k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |